Eupraxia reports positive data from eosinophilic esophagitis treatment trial

Eupraxia reports positive data from eosinophilic esophagitis treatment trial

Source: 
Clinical Trials Arena
snippet: 

Eupraxia Pharmaceuticals has disclosed additional positive data from its Phase Ib/IIa RESOLVE clinical trial of EP-104GI in treating eosinophilic esophagitis (EoE).